Nagashima T, Okazaki H, Kamata Y, Minota S. Comment on “Comparison of MMP-3 levels in rheumatoid arthritis after treatment with tocilizumab or infliximab for 12 weeks” by Yokoe et al.
Mod Rheumatol 2012;
22:638-9; authoe reply 640-2. [DOI:
10.1007/s10165-012-0676-z]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2011] [Accepted: 08/31/2011] [Indexed: 12/01/2022]